utility

header_second

RegMed Investors (RMi) went exclusive on July 27th!

Your complimentary subscription to RegMed Investors’ (RMi) reporting on the stem, cell and gene therapy and RegMed sector has expired.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

It’s up to you to choose the level of content access to provide a premium experience and value - don’t wait to exhale!

I also bring fresh perspectives that yield a whole that is greater than the sum of the parts as I convey a spectrum of factors that explain outcomes, analytical principles and analysis without the encumbrance of trading, investment or I-Banking.

So, after these years of following our facts … first and fast; be part of our “inner circle” as a subscriber!

Stay with me and join our coalition and have a seat at the appreciation table!

Login Sign up now Not now

content_top

34 companies, 1 interpreter! Insight, foresight
and recommendation

Closing Bell

content_middle

Closing Bell

content_right

February 11, 2025 - 4:42pm | Closing Bell
RegMed Investors (RMi) Closing Bell: the sector gets further mutilated

IBB, XBI, VVIX
February 10, 2025 - 4:49pm | Closing Bell
RegMed Investors (RMi) Closing Bell: more of the downdraft as earnings will further their draft

IBB, XBI, VVIX
February 7, 2025 - 5:48pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Sector share pricing wipe-out

IBB, XBI, VVIX
February 6, 2025 - 4:44pm | Closing Bell
RegMed Investors (RMi) Closing Bell: breaking a rack in pool, what’s different?

IBB, XBI, VVIX
February 5, 2025 - 4:46pm | Closing Bell
RegMed Investors (RMi) Closing Bell: back on the horse going forward

IBB, XBI, VVIX
February 4, 2025 - 5:13pm | Closing Bell
RegMed Investors (RMi) Closing Bell: follow the bouncing share pricing

IBB, XBI, VVIX
February 3, 2025 - 6:32pm | Closing Bell
RegMed Investors (RMi) Closing Bell: a roller coaster

IBB, XBI, VVIX
February 1, 2025 - 11:56am | Closing Bell
RegMed Investors (RMi) Closing Bell: another reverse in a volatile week for the cell and gene therapy sector

IBB, XBI, VVIX
January 30, 2025 - 6:54pm | Closing Bell
RegMed Investors (RMi) Closing Bell: share pricing leaps and a few bounds

IBB< XBI, VVIX
January 29, 2025 - 4:47pm | Closing Bell
RegMed Investors (RMi) Closing Bell: a little more of the same

IBB, XBI, VVIX
January 28, 2025 - 4:29pm | Closing Bell
RegMed Investors (RMi) Closing Bell: adding to investor agita

IBB, XBI, VVIX
January 27, 2025 - 4:53pm | Closing Bell
RegMed Investors (RMi) Closing Bell: a strange turn of events

IBB, XBI, VVIX
January 24, 2025 - 4:57pm | Closing Bell
RegMed Investors (RMi) Closing Bell: investor ambiguity points to downdraft of share pricing

IBB, XBI, VVIX
January 23, 2025 - 5:00pm | Closing Bell
RegMed Investors (RMi) Closing Bell: How investors can best navigate the sector ahead

IBB, XBI, VVIX
January 22, 2025 - 4:33pm | Closing Bell
RegMed Investors (RMi) Closing Bell: Getting little too frothy

IBB, XBI, VVIX
January 21, 2025 - 4:33pm | Closing Bell
RegMed Investors (RMi) Closing Bell: a share pricing dose of relief

IBB, XBI, VVIX
January 17, 2025 - 5:15pm | Closing Bell
RegMed Investors (RMi) Closing Bell: the green on the screen as week closes, thankfully

IBB, XBI, VVIX
January 16, 2025 - 4:34pm | Closing Bell
RegMed Investors (RMi) Closing Bell: a sector stampede to the downside

IBB, XBI, VVIX
January 15, 2025 - 4:27pm | Closing Bell
RegMed Investors (RMi) Closing Bell: a sigh of relief

IBB, XBI, VVIX
January 14, 2025 - 4:34pm | Closing Bell
RegMed Investors (RMi) Closing Bell: back in the bag

IBB, XBI, VVIX

Pages

footer

© 2015 RegMed Investors (regmedinvestors.com), all rights are reserved.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry MCusker . Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of RegMed Investors (RM-i); who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other RM-i media services or reposting please email hwm@regmedinvestors.com.